News
The Future of Prostate Cancer Risk Stratification and Treatment Planning
Yale Urology's Preston Sprenkle, MD, and University of Nevada, Reno School of Medicine's Erik Kim, MD, discuss how integrating complex biomarkers into clinical practice might offer more tailored patient care, though challenges remain in managing and interpreting data effectively.
Source: urotoday.com